Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gamma Transcranial Alternating Current Stimulation in Attention Deficit Hyperactivity Disorder

NCT07145593 is registered in ClinicalTrials.gov with Medipol University as lead sponsor.

NCT NCT07145593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07145593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gamma Transcranial Alternating Current Stimulation in Attention Deficit Hyperactivity Disorder
Lead sponsor
Medipol University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
October 1, 2025
Completion date
December 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder with hyperactivity (adhd)